COVID19: Biological E gets nod for phase 2/3 clinical trial for vaccine on children
Biological E has received approval for conducting phase II/III human clinical trial of COVID-19 vaccine candidate Corbevax on children above five years and adolescents.
Sep 03, 2021, 16:33 PM IST